Upload
anaelishockey
View
289
Download
1
Embed Size (px)
Citation preview
ANAELI SHOCKEY LÓPEZUNIVERSITY OF PUERTO RICODEPARTMENT OF CHEMISTRY
BIOL 3095
The use of Cannabis sativa as an anti-inflammatory for Crohn’s
Disease.
Crohn’s Disease
What is it? Inflammatory Bowel Disease (IBD)
Symptoms Abdominal pain
Inflammation Immune system
Vomiting Diarrhea Loss of appetite/weight loss Rectal pain/rectal bleeding
Crohn’s Disease
ReasonsTreatments
Anti-inflammatory agents Topical Antibiotics Immune-modulators No medical cure. (Schoenfeld & Wu. 2010)
Cannabis sativa
What is it?Composition
Cannabinoids Direct involvement with the anti-inflammatory effect
(Burstein, Zurier. 2009) Cannabidiol
Cannabinoid receptors CB1 and CB2 (Pertwee. 2008)
CB1 = brain CB2 = immune system
THC (Δ9-tetrahydrocannabinol) Mediated by the CB1 receptor (Cooper, Haney. 2009)
How does THC affect the brain? Neurotransmiters Specific effects on each part of the brain
Cannabis sativa
Other sicknesses Multiple sclerosis ADHD AIDS Glaucoma Insomnia Asthma Migraines
Cannabis on IBD
Recent treatmentStudies
Mice Inflammation
Croton oil Dinitrobenzene acid
Results: Cannabidiol is active when there is an inflammatory
stimulus. (Capasso, et al. 2008) Cannabidiol reduces colon injury. (Borrelli, et al. 2009)
Cannabis on IBD
Humans Surveys Results
Relieved abdominal pain, diarrhea and reduced appetite. (Lal, et al. 2011)• Endocannabinoids
Protection of the gut against inflammation. (Sabatino, et al. 2011)
Reduced symptoms• Amount of drugs and surgeries needed were reduced.
(Naftali, et al. 2011)
Legalization Issues
CountriesSynthetic cannabis
Structure State
Health effects Unknown according to the Drug Foundation.
Conclusion
Crohn’s Disease IBD
Cannabis sativa Cannabinoids Cannabidiol
Cannabinoid receptors The brain and immune system
Reduced symptoms
References
1. Borrelli F, Aviello G, Romano B, Orlando P, Capasso R, Maiello F, Guadagno F, Petrosino S, Capasso F, Di Marzo V, Izzo A. 2009. Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis. J Mol Med 87:1111–1121. Doi :10.1007/s00109-009-0512-x
2. Burstein S, Zurier R. 2009. Cannabinoids, Endocannabinoids, and Related Analogs in Inflammation. [Internet] [Cited 2012 Nov 24] AAPS J.11(1): 109–119. doi: 10.1208/s12248-009-9084-5 Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2664885/
3. Capasso R, Borrelli F, Aviello G, Romano B, Scalisi C, Capasso F, Izzo AA. 2008.
Cannabidiol, extracted from cannabis sativa, selectively inhibits inflammatory hypermotility in mice. Br J Pharmacol 154(5):1001-8.
4. Cooper Z, Haney M. 2009. Actions of delta-9-tetrahydrocannabinol in cannabis.
Int Rev Psychiatry. [Internet] [Cited 2012 Nov 24] 21(2): 104–112. doi: 10.1080/09540260902782752 Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2731700/
References
5. Di Sabatino A, Battista N, Biancheri P, Rapino C, Rovedatti L, Astarita G, Vanoli A, Dainese E, Guerci M, Piomelli D, Pender S, Pender L, Pender F, MacDonald T, MacDonald T, Maccarrone M, Corazza G, Corazza R. 2011. Mucosal Immunology 4: 574–583; doi:10.1038/mi.2011.18 Available from: http://www.nature.com/mi/journal/v4/n5/full/mi201118a.html
6. Lal S, Prasad N, Ryan M, Tangri S, Silverberg M, Gordon A, Steinhart H. 2011. Cannabis
use amongst patients with inflammatory bowel disease. European Journal of Gastroenterology & Hepatology 23(10):891-896
7. Naftali T, Bar Lev L, Yableknovitz D, Half E and Konikoff F. 2011. Treatment of Crohn’s Disease with Cannabis: An Observational Study. [Internet]. [Cited 2012 Nov 24] 13:455-457 Available from: http://www.letfreedomgrow.com/cmu/Crohns-ar11aug-01.pdf
8. Pertwee RG. 2008. Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Institute of Medical Sciences, Aberdeen, UK. 13(2):147-59.
9. Schoenfeld A, Wu G. 2010. Crohn’s Disease. [Internet] [Cited 2012 Nov 24] Available from: http://www.medicinenet.com/crohns_disease/article.htm
10. Synthetic cannabinoids. Available from: http://www.drugfoundation.org.nz/synthetic-cannabinoids
Questions?